In biomarkers we trust?

被引：112

作者：

Baker, M

机构：

来源：

NATURE BIOTECHNOLOGY | 2005年 / 23卷 / 03期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nbt0305-297

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The 'omics revolution offers plenty of decision-making tools. It's knowing how to use them that's key.

引用

页码：297 / 304

页数：8

共 8 条

[1]

[Anonymous], FRAMEWORK BIOMARKER

[2]

DEMEYER G, 2003, CURR DRUG DISCOV, V12, P23

[3] Surrogate end points in clinical trials: Are we being misled? [J].

Fleming, TR ;

DeMets, DL .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :605-613

[4] Clinical biomarkers in drug discovery and development [J].

Frank, R ;

Hargreaves, R .

NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (07) :566-580

[5] A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer [J].

Paik, S ;

Shak, S ;

Tang, G ;

Kim, C ;

Baker, J ;

Cronin, M ;

Baehner, FL ;

Walker, MG ;

Watson, D ;

Park, T ;

Hiller, W ;

Fisher, ER ;

Wickerham, DL ;

Bryant, J ;

Wolmark, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27) :2817-2826

[6] Use of biomarkers from drug discovery through clinical practice: Report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development [J].

Rolan, P ;

Atkinson, AJ ;

Lesko, LJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) :284-291

[7]

RUBENSTEIN K, 2003, POST GENOMIC BIOMARK

[8] ENDOTHELIN IN HUMAN CONGESTIVE-HEART-FAILURE [J].

WEI, CM ;

LERMAN, A ;

RODEHEFFER, RJ ;

MCGREGOR, CGA ;

BRANDT, RR ;

WRIGHT, S ;

KAO, PC ;

EDWARDS, WD ;

BURNETT, JC ;

HEUBLEIN, DM .

CIRCULATION, 1994, 89 (04) :1580-1586

← 1 →